Rupal P. O'Quinn, MD, MHCI, FACC
Cardiology
Accepting new patients
Sees patients age 18 and up
Penn Cardiology Penn Presbyterian
View 2 additional locations
Schedule onlineCall 215-662-9189
Penn Medicine Provider

About me

  • Director, Cardio-Oncology, Penn Presbyterian Medical Center
  • Associate Professor of Clinical Medicine (Cardiovascular Medicine)

Completed the Master of Health Care Innovation degree at the University of Pennsylvania in May 2023. 

Education and training

  • Medical School: University of Medicine and Dentistry of New Jersey
  • Residency: University of Michigan Medical Center
  • Fellowship: Beth Israel Deaconess Medical Center

What my patients think about me

Average Rating

435 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

October 2025
very thorough
October 2025
it's the top level of care
October 2025
throughout. patient focused.
September 2025
doctor was knowledgeable and professional.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Chester County Hospital: Has privileges to treat patients in the hospital.
Dr. O'Quinn is a Penn Medicine physician. In New Jersey, providers are affiliated with Penn Medicine through Clinical Health Care Associates of New Jersey or Princeton Healthcare Affiliated Physicians, PC.

Qualifications and experience

Treatments and Conditions

My research

Chen YC, Miranda P, Barqawi YK, Fox GE, Chukwu C, Moslehi J, O’Quinn RP Cardiovascular safety outcomes of chronic lymphocytic leukemia treatments: A systematic and targeted literature review. , Crit Rev Oncol Hematol.: 2025

Lenihan D, Bloom M, Copeland-Halperin R, Fleming MR, Fradley M, O'Quinn R, Bhat SA. Considerations for the Practical Management of Cardiovascular Risk With Bruton's Tyrosine Kinase Inhibitors for Patients With CLL , Oncologist: 2025

Tripathi S, O’Quinn R, Cook TS Cardiothoracic Imaging AI for Cardiac Diseases , Semin Roentgenol.: 2025

O’Quinn RP, Desai NR, Dhruva S, Ptaszek LM, Pundi K. Leveraging Apple Watch for Cardiovascular Care. , Accessed August 4, 2025. https://www.acc.org/LeveragingAppleWatch.: 2025

O'Quinn R, Corry AJ, Bajwa N, Jannuru S, Chen H, Miranda P, Brown JR. Cardiac Events in Three Phase 3 Randomized Trials Including Acalabrutinib in Chronic Lymphocytic Leukemia , Clin Lymphoma Myeloma Leuk.: 2025

Pepe V, Afari H, O'Quinn RP, Arjoon R Burkholderia cepacia Endocarditis in a Patient With Severe Mitral Annular Calcification , JACC Case Reports: 2024

Vallabhaneni S, Adusumalli S, Wu J, Groeneveld PW, Gerson J, O'Quinn RP. Cardiotoxicity from bruton tyrosine kinase inhibitors (BTKi)-an analysis of an administrative health claims database. , Cardiooncology: 2024

Yegya-Raman N, Ho Lee S, Friedes C, Wang X, Iocolano M, Kegelman TP, Duan L, Li B, Berlin E, Kim KN, Doucette A, Denduluri S, Levin WP, Cengel KA, Cohen RB, Langer CJ, Kevin Teo BK, Zou W, O'Quinn RP, Deasy JO, Bradley JD, Sun L, Ky B, Xiao Y, Feigenberg SJ. Cardiac radiation dose is associated with inferior survival but not cardiac events in patients with locally advanced non-small cell lung cancer in the era of immune checkpoint inhibitor consolidation. , Radiother Oncol. 2024: 2024

Yegya-Raman N, Kegelman TP, Ho Lee S, Kallan MJ, Kim KN, Natarajan J, Deek MP, Zou W, O'Reilly SE, Zhang Z, Levin W, Cengel K, Kao G, Cohen RB, Sun LL, Langer CJ, Aggarwal C, Singh AP, O'Quinn R, Ky B, Apte A, Deasy J, Xiao Y, Berman AT, Jabbour SK, Feigenberg SJ Death without progression as an endpoint to describe cardiac radiation effects in locally advanced non-small cell lung cancer. , Clin Transl Radiat Oncol.: 2023

Fanaroff AC, Coratti S, Halaby R, Sanghavi M, O'Quinn RP, Krishnan S, Glassberg H, Bajaj A, Adusumalli S, Chokshi N, Patel MS. Feasibility and outcomes from using a commitment devices and text message reminders to increase adherence to time-restricted eating: A randomized trial. , Am Heart J. : 2023